Skip to main content
padlock icon - secure page this page is secure
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 16, Number 3, March 2016

Articles

Free Content Graphical Abstracts:
pp. i-iii(3)

Favourites:
ADD

Free Content Meet Our Editorial Board Member:
pp. 199-199(1)
Author: Holen, Ingunn

Favourites:
ADD

Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy
pp. 200-208(9)
Authors: Andrs, Martin; Korabecny, Jan; Nepovimova, Eugenie; Jun, Daniel; Hodny, Zdenek; Kuca, Kamil

Favourites:
ADD

Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?
pp. 209-214(6)
Authors: Roviello, Giandomenico; Generali, Daniele

Favourites:
ADD

Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation
pp. 215-225(11)
Authors: Arora, Rashi; Sawney, Sharad; Saluja, Daman

Favourites:
ADD

Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
pp. 226-237(12)
Authors: P.R. Xavier, Cristina; Pesic, Milica; Helena Vasconcelos, M.

Favourites:
ADD

Role of Liprins in the Regulation of Tumor Cell Motility and Invasion
pp. 238-248(11)
Authors: Chiaretti, Sara; de Curtis, Ivan

Favourites:
ADD

Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
pp. 249-260(12)
Authors: Nogueira-Rodrigues, A.; Melo, A.C.; Werutsky, G.; Garces, A.H.I.; Ferreira, C.G.

Favourites:
ADD

Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma
pp. 261-274(14)
Authors: Fanelli, Marilù; Maria Hattinger, Claudia; Vella, Serena; Tavanti, Elisa; Michelacci, Francesca; Gudeman, Beth; Barnett, Daryl; Picci, Piero; Serra, Massimo

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more